๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

European experience with screening for neuroblastoma before the age of 12 months

โœ Scribed by Bergeron, C.; Tafese, T.; Kerbl, R.; Craft, A.; Mann, J.; Frappaz, D.


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
85 KB
Volume
31
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


If neuroblastoma is a homogeneous disease, a screening program may be appropriate to detect the condition during the preclinical phase, before symptomatic disease, and it may decrease the overall mortality rate. Six pilot European screening studies were performed in infants to study the feasibility (Newcastle, U.K.; Birmingham, U.K.; Stuttgart, Germany; Hamburg, Germany; Lyon,


๐Ÿ“œ SIMILAR VOLUMES


Neuroblastoma screening in infants postp
โœ Kerbl, Reinhold; Urban, Christian E.; Ladenstein, Ruth; Ambros, Inge M.; Spuller ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 223 KB ๐Ÿ‘ 2 views

## Background: Encouraged by japanese reports of the benefits of screening 6 month-old infants for neuroblastoma, a neuroblastoma screening program was introduced in austria in 1991. however, because of concerns related to "overdiagnosis" by screening at this age, the screening test was performed a

Cyclophosphamide/doxorubicin vs. Cisplat
โœ McWilliams, Nancy B. ;Hayes, F. Ann ;Green, A. A. ;Smith, E. Ide ;Nitschke, Rupr ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 408 KB

## Abstract This prospective study was designed to estimate the response rates and to compare two drug pairs, cyclophosphamide/doxorubicin (Cy/A) and cisplatin/teniposide (P1/VM) in previously untreated patients with disseminated neuroblastoma >12 months of age at diagnosis. Estimated complete clin